Currently, Phio Pharmaceuticals Corp [PHIO] is trading at $6.60, up 290.53%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The PHIO shares have gain 235.03% over the last week, with a monthly amount glided 134.88%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Phio Pharmaceuticals Corp [NASDAQ: PHIO] stock has seen the most recent analyst activity on August 05, 2020, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $4.
This stock has fluctuated between a low of $1.53 and a high of $10.35 over the last 52 weeks. Phio Pharmaceuticals Corp [NASDAQ: PHIO] shares were valued at $6.60 at the most recent close of the market.
Analyzing the PHIO fundamentals
Gross Profit Margin for this corporation currently stands at -1.6% with Operating Profit Margin at -249.53%, Pretax Profit Margin comes in at -247.3%, and Net Profit Margin reading is -247.3%. To continue investigating profitability, this company’s Return on Assets is posted at -1.26, Equity is -1.35 and Total Capital is -1.51.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.8800 points at the first support level, and at 1.1500 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.5600, and for the 2nd resistance point, it is at 12.5100.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Phio Pharmaceuticals Corp [NASDAQ:PHIO] is 6.38. Also, the Quick Ratio is 6.38, while the Cash Ratio stands at 5.87.
Transactions by insiders
Recent insider trading involved Bitterman Robert J, President & CEO, that happened on Jun 07 ’24 when 1000.0 shares were purchased. President & CEO, Bitterman Robert J completed a deal on Jun 06 ’24 to buy 1000.0 shares. Meanwhile, President & CEO Bitterman Robert J bought 2500.0 shares on Feb 26 ’24.
